2021年几内亚埃博拉疫情:埃博拉病毒病患者的临床护理

IF 1.4 Q4 INFECTIOUS DISEASES
Boyo C Pare, Alseny M Camara, Aminata Camara, Moussa Kourouma, Koivogui Enogo, Mohammed S Camara, Laurent Akilimali, Sayadi Sani, Eric Barte de Sainte Fare, Papys Lame, Nicolas Mouly, Marta Lado Castro-Rial, Billy Sivahera, Mahamoud S Cherif, Abdoul H Beavogui, Dally Muamba, Joachim B Tamba, Barry Moumié, Richard Kojan, Hans-Joerg Lang
{"title":"2021年几内亚埃博拉疫情:埃博拉病毒病患者的临床护理","authors":"Boyo C Pare,&nbsp;Alseny M Camara,&nbsp;Aminata Camara,&nbsp;Moussa Kourouma,&nbsp;Koivogui Enogo,&nbsp;Mohammed S Camara,&nbsp;Laurent Akilimali,&nbsp;Sayadi Sani,&nbsp;Eric Barte de Sainte Fare,&nbsp;Papys Lame,&nbsp;Nicolas Mouly,&nbsp;Marta Lado Castro-Rial,&nbsp;Billy Sivahera,&nbsp;Mahamoud S Cherif,&nbsp;Abdoul H Beavogui,&nbsp;Dally Muamba,&nbsp;Joachim B Tamba,&nbsp;Barry Moumié,&nbsp;Richard Kojan,&nbsp;Hans-Joerg Lang","doi":"10.4102/sajid.v38i1.454","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Experience from the Zaire Ebolavirus epidemic in the eastern Democratic Republic of the Congo (2018-2020) demonstrates that early initiation of essential critical care and administration of Zaire Ebolavirus specific monoclonal antibodies may be associated with improved outcomes among patients with Ebola virus disease (EVD).</p><p><strong>Objectives: </strong>This series describes 13 EVD patients and 276 patients with suspected EVD treated during a Zaire Ebolavirus outbreak in Guinea in 2021.</p><p><strong>Method: </strong>Patients with confirmed or suspected EVD were treated in two Ebola treatment centres (ETC) in the region of N'zérékoré. Data were reviewed from all patients with suspected or confirmed EVD hospitalised in these two ETCs during the outbreak (14 February 2021 - 19 June 2021). Ebola-specific monoclonal antibodies, were available 2 weeks after onset of the outbreak.</p><p><strong>Results: </strong>Nine of the 13 EVD patients (age range: 22-70 years) survived. The four EVD patients who died, including one pregnant woman, presented with multi-organ dysfunction and died within 48 h of admission. All eight patients who received Ebola-specific monoclonal antibodies survived. Four of the 13 EVD patients were health workers. Improvement of ETC design facilitated implementation of WHO-recommended 'optimized supportive care for EVD'. In this context, pragmatic clinical training was integrated in routine ETC activities. Initial clinical manifestations of 13 confirmed EVD patients were similar to those of 276 patients with suspected, but subsequently non confirmed EVD. These patients suffered from other acute infections (e.g. malaria in 183 of 276 patients; 66%). Five of the 276 patients with suspected EVD died. One of these five patients had Lassa virus disease and a coronavirus disease 2019 (COVID-19) co-infection.</p><p><strong>Conclusion: </strong>Multidisciplinary outbreak response teams can rapidly optimise ETC design. Trained clinical teams can provide WHO-recommended optimised supportive care, including safe administration of Ebola-specific monoclonal antibodies. Pragmatic training in essential critical care can be integrated in routine ETC activities.</p><p><strong>Contribution: </strong>This article describes clinical realities associated with implementation of WHO-recommended standards of 'optimized supportive care' and administration of Ebola virus specific treatments. In this context, the importance of essential design principles of ETCs is underlined, which allow continuous visual contact and verbal interaction of health workers and families with their patients. Elements that may contribute to further quality of care improvements for patients with confirmed or suspected EVD are discussed.</p>","PeriodicalId":44007,"journal":{"name":"Southern African Journal of Infectious Diseases","volume":"38 1","pages":"454"},"PeriodicalIF":1.4000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900378/pdf/","citationCount":"0","resultStr":"{\"title\":\"Ebola outbreak in Guinea, 2021: Clinical care of patients with Ebola virus disease.\",\"authors\":\"Boyo C Pare,&nbsp;Alseny M Camara,&nbsp;Aminata Camara,&nbsp;Moussa Kourouma,&nbsp;Koivogui Enogo,&nbsp;Mohammed S Camara,&nbsp;Laurent Akilimali,&nbsp;Sayadi Sani,&nbsp;Eric Barte de Sainte Fare,&nbsp;Papys Lame,&nbsp;Nicolas Mouly,&nbsp;Marta Lado Castro-Rial,&nbsp;Billy Sivahera,&nbsp;Mahamoud S Cherif,&nbsp;Abdoul H Beavogui,&nbsp;Dally Muamba,&nbsp;Joachim B Tamba,&nbsp;Barry Moumié,&nbsp;Richard Kojan,&nbsp;Hans-Joerg Lang\",\"doi\":\"10.4102/sajid.v38i1.454\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Experience from the Zaire Ebolavirus epidemic in the eastern Democratic Republic of the Congo (2018-2020) demonstrates that early initiation of essential critical care and administration of Zaire Ebolavirus specific monoclonal antibodies may be associated with improved outcomes among patients with Ebola virus disease (EVD).</p><p><strong>Objectives: </strong>This series describes 13 EVD patients and 276 patients with suspected EVD treated during a Zaire Ebolavirus outbreak in Guinea in 2021.</p><p><strong>Method: </strong>Patients with confirmed or suspected EVD were treated in two Ebola treatment centres (ETC) in the region of N'zérékoré. Data were reviewed from all patients with suspected or confirmed EVD hospitalised in these two ETCs during the outbreak (14 February 2021 - 19 June 2021). Ebola-specific monoclonal antibodies, were available 2 weeks after onset of the outbreak.</p><p><strong>Results: </strong>Nine of the 13 EVD patients (age range: 22-70 years) survived. The four EVD patients who died, including one pregnant woman, presented with multi-organ dysfunction and died within 48 h of admission. All eight patients who received Ebola-specific monoclonal antibodies survived. Four of the 13 EVD patients were health workers. Improvement of ETC design facilitated implementation of WHO-recommended 'optimized supportive care for EVD'. In this context, pragmatic clinical training was integrated in routine ETC activities. Initial clinical manifestations of 13 confirmed EVD patients were similar to those of 276 patients with suspected, but subsequently non confirmed EVD. These patients suffered from other acute infections (e.g. malaria in 183 of 276 patients; 66%). Five of the 276 patients with suspected EVD died. One of these five patients had Lassa virus disease and a coronavirus disease 2019 (COVID-19) co-infection.</p><p><strong>Conclusion: </strong>Multidisciplinary outbreak response teams can rapidly optimise ETC design. Trained clinical teams can provide WHO-recommended optimised supportive care, including safe administration of Ebola-specific monoclonal antibodies. Pragmatic training in essential critical care can be integrated in routine ETC activities.</p><p><strong>Contribution: </strong>This article describes clinical realities associated with implementation of WHO-recommended standards of 'optimized supportive care' and administration of Ebola virus specific treatments. In this context, the importance of essential design principles of ETCs is underlined, which allow continuous visual contact and verbal interaction of health workers and families with their patients. Elements that may contribute to further quality of care improvements for patients with confirmed or suspected EVD are discussed.</p>\",\"PeriodicalId\":44007,\"journal\":{\"name\":\"Southern African Journal of Infectious Diseases\",\"volume\":\"38 1\",\"pages\":\"454\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900378/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Southern African Journal of Infectious Diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4102/sajid.v38i1.454\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Southern African Journal of Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4102/sajid.v38i1.454","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

背景:刚果民主共和国东部扎伊尔埃博拉病毒流行(2018-2020年)的经验表明,早期开始基本重症监护和给予扎伊尔埃博拉病毒特异性单克隆抗体可能与改善埃博拉病毒病(EVD)患者的预后有关。目的:本系列描述了2021年几内亚扎伊尔埃博拉病毒暴发期间治疗的13名埃博拉病毒病患者和276名疑似埃博拉病毒病患者。方法:对确诊或疑似EVD患者在恩扎伊姆萨伊地区的两个埃博拉治疗中心(ETC)进行治疗。对疫情暴发期间(2021年2月14日至2021年6月19日)在这两个ETCs住院的所有疑似或确诊埃博拉病毒病患者的数据进行了审查。在疫情发生2周后可获得埃博拉特异性单克隆抗体。结果:13例EVD患者中9例存活,年龄22 ~ 70岁。死亡的4例EVD患者,包括1名孕妇,均出现多器官功能障碍,并在入院48小时内死亡。接受埃博拉特异性单克隆抗体治疗的8名患者全部存活。13名埃博拉患者中有4名是卫生工作者。ETC设计的改进促进了世卫组织建议的“埃博拉病毒病优化支持性护理”的实施。在这种情况下,实用的临床培训被纳入日常的ETC活动。13例确诊埃博拉病毒病患者的初始临床表现与276例疑似埃博拉病毒病患者相似,但随后未确诊。这些患者患有其他急性感染(例如,276名患者中有183名患有疟疾;66%)。276名疑似埃博拉病毒病患者中有5人死亡。这五名患者中有一人同时感染了拉沙病毒病和2019年冠状病毒病(COVID-19)。结论:多学科疫情响应团队可快速优化ETC设计。训练有素的临床小组可以提供世卫组织推荐的优化支持性护理,包括安全给药埃博拉特异性单克隆抗体。关键重症监护方面的实用培训可以纳入日常的ETC活动。贡献:本文描述了与实施世卫组织推荐的“优化支持性护理”标准和实施埃博拉病毒特异性治疗相关的临床现实。在这种情况下,强调了ETCs基本设计原则的重要性,这些原则允许卫生工作者和家属与患者进行持续的视觉接触和口头互动。讨论了可能有助于进一步改善确诊或疑似埃博拉病毒病患者护理质量的因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Ebola outbreak in Guinea, 2021: Clinical care of patients with Ebola virus disease.

Ebola outbreak in Guinea, 2021: Clinical care of patients with Ebola virus disease.

Ebola outbreak in Guinea, 2021: Clinical care of patients with Ebola virus disease.

Background: Experience from the Zaire Ebolavirus epidemic in the eastern Democratic Republic of the Congo (2018-2020) demonstrates that early initiation of essential critical care and administration of Zaire Ebolavirus specific monoclonal antibodies may be associated with improved outcomes among patients with Ebola virus disease (EVD).

Objectives: This series describes 13 EVD patients and 276 patients with suspected EVD treated during a Zaire Ebolavirus outbreak in Guinea in 2021.

Method: Patients with confirmed or suspected EVD were treated in two Ebola treatment centres (ETC) in the region of N'zérékoré. Data were reviewed from all patients with suspected or confirmed EVD hospitalised in these two ETCs during the outbreak (14 February 2021 - 19 June 2021). Ebola-specific monoclonal antibodies, were available 2 weeks after onset of the outbreak.

Results: Nine of the 13 EVD patients (age range: 22-70 years) survived. The four EVD patients who died, including one pregnant woman, presented with multi-organ dysfunction and died within 48 h of admission. All eight patients who received Ebola-specific monoclonal antibodies survived. Four of the 13 EVD patients were health workers. Improvement of ETC design facilitated implementation of WHO-recommended 'optimized supportive care for EVD'. In this context, pragmatic clinical training was integrated in routine ETC activities. Initial clinical manifestations of 13 confirmed EVD patients were similar to those of 276 patients with suspected, but subsequently non confirmed EVD. These patients suffered from other acute infections (e.g. malaria in 183 of 276 patients; 66%). Five of the 276 patients with suspected EVD died. One of these five patients had Lassa virus disease and a coronavirus disease 2019 (COVID-19) co-infection.

Conclusion: Multidisciplinary outbreak response teams can rapidly optimise ETC design. Trained clinical teams can provide WHO-recommended optimised supportive care, including safe administration of Ebola-specific monoclonal antibodies. Pragmatic training in essential critical care can be integrated in routine ETC activities.

Contribution: This article describes clinical realities associated with implementation of WHO-recommended standards of 'optimized supportive care' and administration of Ebola virus specific treatments. In this context, the importance of essential design principles of ETCs is underlined, which allow continuous visual contact and verbal interaction of health workers and families with their patients. Elements that may contribute to further quality of care improvements for patients with confirmed or suspected EVD are discussed.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
11.10%
发文量
50
审稿时长
52 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信